Orencia Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes
Conditions:   Type 1 Diabetes;   Diabetes Mellitus, Type 1 Interventions:   Drug: Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®);   Drug: Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride) Sponsors:   Melbourne Health;   National Health and Medical Research Council, Australia;   Juvenile Diabetes Research Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Condition:   Graft Vs Host Disease Interventions:   Drug: Cyclophosphamide;   Drug: Abatacept;   Drug: Tacrolimus Sponsor:   NYU Langone Health Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2022 Category: Research Source Type: clinical trials